本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amneal Pharmaceuticals, Inc.

17.15
+0.14000.82%
成交量:5.83萬
成交額:99.66萬
市值:54.71億
市盈率:35.67
高:17.23
開:17.11
低:17.04
收:17.01
52周最高:19.26
52周最低:9.49
股本:3.19億
流通股本:1.91億
量比:1.06
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):0.4808
每股收益(LYR):0.2200
淨資產收益率:613.02%
總資產收益率:8.60%
市淨率:165.66
市盈率(LYR):77.95

資料載入中...

2023/11/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/05/20

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

重要事件披露

Form 8-K - Current report
2023/04/17

重要事件披露

8-K - Current report
2023/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]